Merck Competitors

Stocks . Germany . 
Stock . Merck KGaA
MRK Stock   137.85  0.35  0.25%   
Merck KGaA competes with Haleon PLC, LIVZON PHARMAC, SIMCERE PHARMAC, and CanSino Biologics; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. Analyzing Merck KGaA competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Merck KGaA to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Merck KGaA Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Merck KGaA competition on your existing holdings.
  
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merck KGaA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
136.34137.85139.36
Details
Intrinsic
Valuation
LowRealHigh
119.80121.31151.64
Details
Naive
Forecast
LowNextHigh
131.20132.71134.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
122.16140.91159.67
Details

Merck KGaA Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Merck KGaA and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Merck and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Merck KGaA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
R2WA
+ 0.73
CJH
R2WA
+ 0.73
EVT
CJH
+ 0.69
S2P
EVT
+ 0.68
CJH
R2WA
+ 0.67
S2P
R2WA
+ 0.63
DMP
  
High negative correlations   
EVT
- 0.87
MRK
R2WA
- 0.8
MRK
DMP
- 0.75
MRK
CJH
- 0.68
MRK
S2P
- 0.58
MRK
EVT
- 0.51
H6D

Risk-Adjusted Indicators

There is a big difference between Merck Stock performing well and Merck KGaA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Merck KGaA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Merck KGaA Competitive Analysis

The better you understand Merck KGaA competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Merck KGaA's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Merck KGaA's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MRK H6D LP6 S2P CJH EVT DMP BSFA R2WA
 0.25 
 137.85 
Merck
 0.55 
 9.10 
Haleon
 5.59 
 3.40 
LIVZON
 1.22 
 0.81 
SIMCERE
 3.17 
 3.66 
CanSino
 0.12 
 8.41 
Evotec
 0.53 
 37.80 
Dermapharm
 1.92 
 51.00 
ANI
 0.00 
 0.41 
BEXIMCO
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Relatively risky
Dangerous
Risky
Relatively risky
Very steady
Very steady
Out of control
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Modest
Insignificant
OK
OK
Modest
Very Weak
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Below Average
Low
Below Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Strong Sell
Hold
Strong Hold
Strong Sell
Strong Sell
Hold
Sell
Current Ratio
N/A
N/A
2.6
N/A
N/A
N/A
N/A
N/A
2.26
Net Asset
45.36 B
N/A
N/A
N/A
11.87 B
2.24 B
1.41 B
771.6 M
N/A
Profit Margin
0.16
0.13
0.15
0.18
N/A
-0.26
0.17
-0.24
0.14
EBITDA
5.95 B
2.28 B
2.3 B
743.59 M
2.05 B
316.63 M
357.65 M
3.12 M
N/A
Operating Margin
0.23
0.2
0.15
0.0982
N/A
-0.0054
0.26
-0.13
N/A
Current Valuation
87.36 B
44 B
N/A
N/A
3.4 B
2.54 B
2.68 B
894.88 M
N/A
Price To Book
2.77
1.05
N/A
N/A
2.25
2.34
4.69
2.16
N/A
Beta
0.65
N/A
0.51
0.48
0.61
1.01
1.2
1.06
0.8
Number Of Employees
63.72 K
22 K
8.58 K
6.54 K
9
4.71 K
2.37 K
601
5.5 K
Shares Outstanding
129.24 M
4.62 B
309.83 M
2.66 B
114.78 M
176.95 M
53.84 M
17.45 M
446.11 M
Cash Flow From Operations
4.62 B
N/A
192.47 M
N/A
2.05 B
122.24 M
250.37 M
3.32 M
N/A
Annual Yield
0.0103
N/A
0.0594
0.0182
0.0156
N/A
0.0564
N/A
0.0613
Total Debt
30.69 B
N/A
22.97 M
N/A
40 M
462.31 M
574.72 M
286.52 M
N/A
Return On Equity
0.14
N/A
0.13
0.17
0.0111
-0.16
0.38
-0.26
0.12
Z Score
1.2
N/A
N/A
N/A
47.4
3.6
1.8
1.2
N/A
Return On Asset
0.0656
N/A
0.0514
0.0344
-0.0207
-0.0012
0.12
-0.0374
0.0659
Book Value Per Share
64.91
5.82
14.37
2.32
29.22
6.95
9.36
19.11
N/A
Total Asset
45.36 B
N/A
N/A
N/A
11.87 B
2.24 B
1.41 B
771.6 M
N/A
Target Price
209.1
N/A
N/A
N/A
N/A
27.1
56.3
N/A
N/A
Last Dividend Paid
1.85
N/A
1.3
0.15
N/A
N/A
2.17
N/A
N/A
Debt To Equity
N/A
N/A
1.3
N/A
N/A
N/A
N/A
N/A
27.5
Shares Owned By Institutions
60.26
7.38
14.83
4.7
38.77
66.45
17.12
75.34
2.09
Market Capitalization
76.08 B
33.85 B
3.86 B
3.75 B
3.2 B
2.94 B
2.1 B
699.18 M
563.15 M
Price To Earnings To Growth
3.09
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
4.02
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
3.64
3.19
N/A
N/A
2.17
3.91
2.04
2.23
N/A
Net Income
3.06 B
N/A
684.16 M
N/A
1.91 B
215.51 M
209.58 M
(42.6 M)
N/A
Earnings Per Share
7.98
0.33
0.27
0.05
0.52
-1.0
3.32
-4.46
0.1
Shares Owned By Insiders
N/A
6.4
52.73
69.2
26.7
9.86
65.04
13.11
N/A
Revenue
19.69 B
10.56 B
12.18 B
5.58 B
4.3 B
618.03 M
942.91 M
216.14 M
N/A
Cash And Equivalents
N/A
N/A
1.14 B
N/A
N/A
699.33 M
161.38 M
N/A
N/A
Cash Per Share
N/A
N/A
1.58
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
12.36 B
5.99 B
7.75 B
3.92 B
1.03 B
151.54 M
610.22 M
117.43 M
15.71 B
Day Typical Price
137.9
9.1
3.33
0.81
3.66
8.35
37.77
51.0
0.41
Accumulation Distribution
0.0148
N/A
0.0588
N/A
N/A
0.0202
0.0079
N/A
N/A
Market Facilitation Index
2.05
N/A
0.2
N/A
N/A
0.17
0.3
N/A
N/A
Daily Balance Of Power
(0.17)
(9,223,372,036,855)
0.9
(9,223,372,036,855)
(9,223,372,036,855)
0.0588
(0.67)
(9,223,372,036,855)
0.0
Period Momentum Indicator
(0.35)
(0.05)
0.18
(0.01)
(0.12)
0.01
(0.20)
(1.00)
N/A
Rate Of Daily Change
1.0
0.99
1.06
0.99
0.97
1.0
0.99
0.98
1.0
Day Median Price
137.93
9.1
3.3
0.81
3.66
8.32
37.75
51.0
0.41
Price Action Indicator
(0.25)
(0.03)
0.19
(0.01)
(0.06)
0.09
(0.05)
(0.50)
N/A
Coefficient Of Variation
(893.97)
31414.27
805.57
1140.9
694.59
800.86
1029.16
(5,233)
417.2
Mean Deviation
1.04
1.28
1.68
2.07
3.59
3.86
1.37
1.56
2.76
Jensen Alpha
(0.19)
(0.01)
0.3218
0.2564
0.7337
0.7737
0.1895
(0.09)
1.03
Total Risk Alpha
(0.25)
(0.08)
0.2044
0.1245
0.5237
0.4689
0.1
(0.14)
0.8383
Sortino Ratio
N/A
(0.02)
0.0921
0.0665
0.1532
0.1216
0.1008
N/A
0.1775
Downside Variance
N/A
3.04
9.58
11.13
22.05
32.16
2.34
N/A
31.2
Standard Deviation
1.53
1.66
2.66
3.04
5.31
5.88
2.05
2.01
4.32
Kurtosis
9.1
0.4199
7.72
3.99
2.15
3.3
4.42
(0.35)
6.58
Potential Upside
2.08
2.84
5.59
5.13
13.07
9.76
3.97
3.41
6.45
Treynor Ratio
(0.58)
(0.47)
(5.84)
37.74
1.27
(0.51)
(10.61)
(0.04)
35.14
Maximum Drawdown
10.92
8.17
20.56
18.98
30.83
36.91
10.99
9.18
32.13
Variance
2.35
2.76
7.06
9.25
28.18
34.59
4.19
4.04
18.69
Market Risk Adjusted Performance
(0.57)
(0.46)
(5.83)
37.75
1.28
(0.50)
(10.60)
(0.03)
35.15
Risk Adjusted Performance
(0.08)
0.0077
0.1062
0.0775
0.1236
0.1085
0.0838
(0.01)
0.1998
Skewness
2.0
0.1467
(0.82)
0.3786
0.6423
0.5326
1.29
0.0263
1.31
Semi Deviation
N/A
1.49
2.31
2.48
3.56
4.65
1.31
N/A
2.28
Information Ratio
(0.14)
(0.02)
0.1073
0.0729
0.1355
0.1173
0.0753
(0.04)
0.2293
Value At Risk
(2.09)
(2.34)
(2.58)
(3.85)
(5.82)
(8.38)
(2.35)
(3.30)
(4.00)
Expected Short fall
N/A
(1.57)
(2.31)
(2.79)
(4.42)
(4.22)
(1.94)
N/A
(5.59)
Downside Deviation
N/A
1.74
3.09
3.34
4.7
5.67
1.53
N/A
5.59
Semi Variance
N/A
2.23
5.36
6.17
12.64
21.62
1.73
N/A
5.18

Merck KGaA Competition Performance Charts

Five steps to successful analysis of Merck KGaA Competition

Merck KGaA's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Merck KGaA in relation to its competition. Merck KGaA's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Merck KGaA in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Merck KGaA's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Merck KGaA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Merck KGaA position

In addition to having Merck KGaA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wireless Thematic Idea Now

Wireless
Wireless Theme
Companies providing wireless technology and communication services. The Wireless theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Merck Stock Analysis

When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY